ARTICLE;
CASE REPORT;
CENTRAL NERVOUS SYSTEM;
CENTRAL NERVOUS SYSTEM DEPRESSION;
CHILD;
COMA;
CONCENTRATION (PARAMETERS);
DRUG ABSORPTION;
DRUG OVERDOSE;
FEMALE;
HEALTH CARE FACILITY;
HEART ARRHYTHMIA;
HUMAN;
INTUBATION;
MALE;
PATIENT CARE;
PATIENT REFERRAL;
SEIZURE;
TOXICOKINETICS;
2002 Annual report of the American Association of Poison Centers Toxic Exposure Surveillance System
Watson WA, Litovitz TL, Rodgers GC, et al. 2002 Annual report of the American Association of Poison Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2003;21(5):353-421.
Feasibility and pharmacokinetics of carbamazepine oral loading does
Cohen H, Rowland MA, Luciano DJ, et al. Feasibility and pharmacokinetics of carbamazepine oral loading does. Am J Health Syst Pharm. 1998;55:1134-1140.
Clinical features in 28 consecutive cases of laboratory confirmed massive poisoning with carbamazepine alone
Hojer J, Malmlund HO, Berg A. Clinical features in 28 consecutive cases of laboratory confirmed massive poisoning with carbamazepine alone. J Toxicol Clin Toxicol. 1993;31(3):449-458.
Massive carbamazepine overdose: Clinical and pharmacological observations in five episodes
Weaver DF, Camfield P, Fraser, A. Massive carbamazepine overdose: clinical and pharmacological observations in five episodes. Neurology. 1988;38:755-759.
Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning
AAMT and EAPCCT. Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. J Toxicol Clin Toxicol. 1999;37(6):731-751.